Sanjay Kulshreshtha

Sanjay Kulshreshtha, listed as chief executive, appears in our data through filings on Dr. Lal Path Labs Ltd. shares, published by SEBI (PIT + SAST). The record holds 17 filings, for trades running from 18 May 2021 to 30 December 2025.

On the open market, the record shows 1 purchase worth €7,679 and 7 sales worth €98k. The net balance comes to €90k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 9 share grants. So far in 2025, the count stands at no purchases and 2 sales.

Most recently, on 30 December 2025, the filings show a share grant worth €24 in Dr. Lal Path Labs Ltd. The most recent open-market purchase was published on 14 September 2021, 1,860 days ago. Filings reach the SEBI (PIT + SAST) feed a median of 2 days after the trade. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.